ISCHEMIC ACUTE KIDNEY INJURY (AKI) is the most common form of AKI in the adult population. Prominent morphologic features of ischemic AKI include effacement and loss of the proximal tubule brush border and patchy loss of tubular cells, focal areas of proximal tubule dilation and distal tubular casts, and areas of cellular regeneration (8) . To date, the molecular basis of the events leading to tubule regeneration after AKI has been only partially established. The mechanisms that lead to renal cell proliferation and regeneration must be better understood before novel therapeutic strategies for the treatment of ischemic AKI can be explored. Evidence has suggested that regeneration processes may recapitulate developmental processes to restore organ or tissue function (1, 32) . Adult tubule epithelial cells have a potent ability to regenerate after cellular damage (6) . In organisms that have suffered ischemic renal damage, normally quiescent cells de-differentiate and acquire the ability to proliferate through enhancements in DNA synthesis (24, 33) .
Regeneration processes may be similar to developmental processes. Embryonic genes such as Wnt-4 and Notch-2 are markedly induced in the mature kidney after ischemic renal injury and apparently play crucial roles in the regeneration and repair of this organ (14, 19, 26, 28) .
Hepatocyte nuclear factor-1␤ (HNF-1␤) is a transcription factor expressed in the kidney, liver, pancreas, and other epithelial organs (13, 23) . Mutations of HNF-1␤ cause maturity-onset diabetes of the young type 5 (MODY5), which is characterized by early onset diabetes mellitus and congenital malformations of the kidney and genital tract (9) . Knockout of HNF-1␤ in the mouse kidney results in cyst formation (31) . Recently, HNF-1␤ was reported to bind to the suppressor of cytokine signaling-3 (SOCS-3) promoter and repress SOCS-3 transcription (36) . However, the signaling pathways and transcriptional programs controlled by HNF-1␤ in ischemia/reperfusion renal injury are poorly understood.
The aims of this study were to investigate the functional roles of HNF-1␤, SOCS-3, and signal transducer and activator of transcription 3 (STAT3) in tubule damage after AKI both in vivo and in vitro and to examine the signaling pathway used by HNF-1␤, SOCS-3, and STAT3 in renal tubular cells. Our data demonstrate that HNF-1␤ is upregulated during ischemia/ reperfusion renal tubule injury in proximal tubular cells in vivo and that HNF-1␤ controls cellular proliferation and regeneration by regulating SOCS-3 expression and STAT3/Erk activation. Therefore, the current study unravels the physiological and pathological significance of the HNF-1␤ pathway in ischemia/reperfusion renal injury in vivo and in vitro.
MATERIALS AND METHODS

Induction of AKI.
Male Sprague-Dawley (SD) rats (Saitama Experimental Animal Supply, Saitama, Japan) weighing 150 -200 g were anesthetized by intraperitoneal injection of sodium pentobarbital (30 mg/kg) before surgery. The left renal artery was occluded with Sugita aneurysm clips (Mizuho Ikakogyo, Tokyo, Japan) for 1 h. The clamps were removed, the incisions were closed, and the rats were killed at 0, 3, 6, 12, 24, 48 , and 72 h after reperfusion (n ϭ 5 per group). The left kidney was quickly removed and processed for histological evaluation, protein extraction, or RNA extraction (26, 28) . Age-and weight-matched SD rats underwent sham operations without clamping of the renal arteries, and kidneys were collected at 0 and 12 h after surgery (n ϭ 3 per group). All animal protocols were approved by the Institutional Animal Care and Use Committee at the University of Kochi (no. 20 -024) and conducted in accordance with institutional guidelines.
Cell culture and plasmids. NRK-52E cells (renal tubular cells of adult rat kidney) originally purchased from American Type Culture Collection (Rockville, MD) were grown in DMEM supplemented with 50 IU/ml penicillin and 10% heat-inactivated FCS (GIBCO; Ref. 26) . Human wild-type HNF-1b and HNF-1b-H153N [dominant-negative (DN) type] expression vectors were a kind gift from Jun Takeda (Gifu University, Gifu, Japan). SOCS-3 expression vector and promoter (Ϫ2.5 kb) luciferase plasmid were obtained from Addgene (Rockville, MD). NRK-52E cells were transfected by the electroporation method as previously described (28) . Plasmid DNA (10 g) was transfected by electroporation. Luciferase activity was measured 48 h after transfection. Normalization was achieved by cotransfecting a ␤-galactosidase reporter construct. To determine the efficiency of transfection, we transfected a GFP-expressing plasmid as a control by using the same electroporation method used in the promoter assay.
Isolation of kidney tissue and histological examination. Rats were anesthetized with pentobarbital at indicated times after ischemia. Their kidneys were perfused with sterile PBS. The left kidney was quickly excised, frozen in liquid nitrogen, and homogenized in the SDS sample buffer described below.
For immunohistochemical studies, renal tissues were fixed in formalin overnight and then dehydrated and embedded in paraffin. Thin sections were examined with periodic acid Schiff staining, as described previously (26) . Immunohistochemical staining was performed by a streptavidin and biotin technique using an anti-HNF-1␤-specific antibody (N-276, cs-111; Santa Cruz Biochemical) and an anti-aquaporin-1-specific antibody (B-11, sc-25287; Santa Cruz Biochemical) as a marker for proximal tubules, as described previously (7, 34) . The sequence of the blocking peptide for the HNF-1␤ antibody was as follows: CGEEWSQDLHSSGRTDLRYS. The blocking peptide (10 g/ml) was preloaded onto histology sections or immunoblot membranes before addition of the antibody.
Western blot analysis. Fifty micrograms of protein sample (total renal tissue or NRK-52E cells) prepared as described above were denatured at 100°C for 5 min in SDS sample buffer and then separated by 7.5 or 10/20% PAGE (29) . Proteins were transferred to a nitrocellulose membrane, blocked for 1 h with 5% (wt/vol) fat-free milk powder, and probed with primary antibody. Western blot analysis was performed using an anti-HNF-1␤-, SOCS-3-, and polycystic kidney disease 2 (PKD2)-specific antibody, an anti-SOCS-3-specific antibody, an anti-PKD2-specific antibody (Val-1744; Cell Signaling Technology), an anti-HNF-1␤-specific antibody (N-276, cs-111; Santa Cruz Biochemical), an anti-actin-specific antibody (H-300, sc-10731; Santa Cruz Biochemical), an anti-cyclin D1-specific antibody (cs-753; Santa Cruz Biochemical), an anti-proliferating cell nuclear antigen (PCNA)-specific antibody (sc-7907; Santa Cruz Biochemical), an anti-cleaved caspase-3-specific antibody (sc-22171; Santa Cruz Biochemical), an anti-phospho-STAT3(Tyr-705)-specific antibody (N-276, cs-7993; Santa Cruz Biochemical), and an antiphospho-STAT3(Ser-727)-specific antibody (sc-21876; Santa Cruz Biochemical). Primary antibodies were detected using horseradishperoxidase-conjugated rabbit anti-goat IgG and donkey anti-rabbit IgG and visualized using an ECL system (Amersham, Arlington Heights, IL). The intensities of the bands were quantitated using Molecular Dynamic ImageQuant Software (Sunnyvale, CA).
Real-time quantitative PCR. RT-PCR analysis with RNA extracted from kidneys was carried out as previously described (30 Fig. 1 . Real-time PCR analysis of mRNA expression after ischemia/reperfusion acute renal injury. Bilateral renal arteries were clamped for 1 h and kidneys were excised at 3, 6, 12, 24, 48, and 72 h after reperfusion. Shamoperated rats at 0 h served as controls. Extracted total RNA was subjected to quantitative PCR using the LightCycler real-time PCR system for the estimation of relative hepatocyte nuclear factor-1␤ (HNF-1␤), suppressor of cytokine signaling-3 (SOCS-3), and polycystic kidney disease 2 (PKD2), and Pkhd1 mRNA levels, as well as the ratio of gene expression to GAPDH mRNA expression, as described in the MATERIALS AND METHODS. Each column with a bar represents the means Ϯ SE (n ϭ 5). *P Ͻ 0.05 vs. control rats (sham operated).
were redissolved in 0.5 M NaOH and counted in Aquasol-2 scintillation cocktail (NEN Research Products, Boston, MA; Ref.
27).
Tubulogenesis in three-dimensional collagen gels. Cells were trypsinized to form a single-cell suspension and mixed with collagen gel solution at a concentration of 100,000 cells/ml, as previously reported (36, 18) . The collagen gels were allowed to polymerize at 37°C for 4 h, and media containing 2% FCS were added. Tubule formation was induced by of hepatocyte growth factor (HGF; 10 ng/ml), and tubulogenesis was quantified as described previously (2) .
Caspase-3 assay and lactate dehydrogenase release assay. A caspase-3 fluorometric protease assay kit and lactate dehydrogenase (LDH) assay kit (MBL, Tokyo, Japan) were used for the measurement of caspase-3 activity and LDH measurement, as previously described (27) . In brief, the cell lysates were incubated with a reaction buffer and a 50 mM caspase-3 substrate for 2 h at 37°C, and the caspase-3 enzymatic activity was measured colorimetrically.
Statistics. The results are presented as means Ϯ SE. The significance of differences between groups was tested using a two-way ANOVA followed by Scheffé's test for multiple comparisons. Two groups were compared by the unpaired t-test. P Ͻ 0.05 was considered significant.
RESULTS
mRNA expressions of HNF-1␤, SOCS-3, and PKD2 after ischemia/reperfusion acute renal injury.
To examine the changes in expressions of HNF-1␤, SOCS-3, and PKD2 during AKI, we conducted real-time quantitative polymerase PCR analysis of rat kidney mRNA after ischemia/reperfusion. The left renal artery was clamped for 1 h, and the left kidney was excised at 3, 6, 12, 24, 48, and 72 h after reperfusion. Shamoperated kidneys were used as controls. The target genes of HNF-1␤ include cystic genes and other types of genes (Pkhd1, Pkd2, Kif12, Umod, and Socs-3; Refs. 11, 12, 36). For our study, we performed real-time quantitative PCR analysis of these target gene mRNAs for screening purposes (Fig. 1) . The mRNA level of HNF-1␤ was dramatically elevated from 3 to 24 h after ischemia/reperfusion injury (Fig. 1A) . We detected strong signals and changes in SOCS-3 and PKD2 expressions after ischemia/reperfusion. Quantitative real-time RT-PCR assay revealed significant decreases in SOCS-3 mRNA levels at 3-12 h after reperfusion, when compared with the control value (Fig. 1B) . The mRNA level of PKD2 was dramatically elevated from 6 to 48 h after ischemia/reperfusion injury (Fig.  1C ). Pkhd1 mRNA level was not changed after ischemia/ reperfusion under our experimental conditions (Fig. 1D) . The mRNA levels of Kif12 and Umod were also not changed after ischemia/reperfusion (data are not shown).
Protein expressions of HNF-1␤, SOCS-3, and PKD2 after ischemic renal injury.
Western blot analyses were performed after ischemia/reperfusion of the kidneys to detect the protein levels of HNF-1␤, SOCS-3, and PKD2. The HNF-1␤ protein expression level increased dramatically but transiently compared with the control (sham-operated) at 3-12 h after ischemia/reperfusion ( Fig. 2A) . Later, at 24 -72 h after ischemia/ reperfusion, the intensity of the HNF-1␤ band gradually decreased. Quantitative analysis using a densitometer revealed 2.5-fold (3 h), 5.6-fold (6 h), and 3.3-fold (12 h) increases in HNF-1␤ protein levels compared with the control level (Fig.   2B ). The expression level of SOCS-3 was significantly decreased 3-24 h after ischemia/reperfusion ( Fig. 2A) . Quantitative analysis revealed 0.43-fold (3 h), 0.42-fold (6 h), 0.35-fold (12 h), and 0.40-fold (24 h) decreases in SOCS-3 protein levels compared with the control level (Fig. 2B) . PKD2 protein expression levels increased compared with the control (shamoperated) at 6 -48 h after ischemia/reperfusion ( Fig. 2A) . Quantitative analysis revealed 6.8-fold (6 h), 7.5-fold (12 h), 8.9-fold (24 h), and 6.3-fold (48 h) increases in PKD2 protein levels compared with the control level (Fig. 2B) .
Immunohistochemical examination of HNF-1␤ after ischemic renal injury. Next, we performed immunohistological studies on HNF-1␤ after ischemia/reperfusion AKI (Fig. 3) . Under low-power magnification, HNF-1␤ expression was observed in cortical renal tubules at 12 h after ischemia/reperfusion (Fig. 3B) . On the other hand, only weak HNF-1␤ expression was observed in the renal cortex from control rats (Fig.  3A) . Under higher magnification, HNF-1␤ staining was observed in the nuclei of proximal tubular cells (Fig. 3C) . To examine the specificity of the HNF-1␤ antibody, we used a blocking peptide. The nuclear signal in the cortex of ischemia/ reperfusion kidneys diminished in the presence of the blocking peptide (Fig. 3D) . We used an anti-aquaporin-1 antibody as a marker of proximal tubules (7, 34) . As shown in Fig. 3E and F, and at 12 h after ischemic injury (B) were assessed under low-power magnification (ϫ100). C: immunohistochemical analyses of the renal cortex performed using an antibody against HNF-1␤ at 12 h after ischemic injury were assessed under high-power magnification (ϫ600) Arrows indicates HNF-1␤-positive cells. D: immunohistochemical analyses of the renal cortex performed using an antibody against HNF-1␤ at 12 h after ischemic injury in the presence of the blocking peptide for HNF-1␤ were assessed under low-power magnification (ϫ100). E and F: immunohistochemical analyses of the renal cortex performed using antibodies against HNF-1␤ (E) and aquaporin-1 (F) at 12 h after ischemic injury were assessed in serial sections under low-power magnification (100ϫ).
the expression of HNF-1␤ was colocalized with aquaporin-1 under low-power examination of serial sections. These results show that HNF-1␤ was expressed mainly in the proximal tubules of the renal cortex 12 h after ischemia/reperfusion.
Overexpression of HNF-1␤ suppresses promoter activity and expression of SOCS-3 and stimulates proliferation of NRK-52E cells.
We first examined the effects of overexpression of HNF-1␤ on the regulation of SOCS-3 promoter activity and protein expression. We performed a transient transfection with a SOCS-3-luciferase reporter gene and wild-type HNF-1␤ or HNF-1␤-H153N (DN type) expression vectors. When wildtype HNF-1␤ was overexpressed in NRK-52E cells, SOCS-3 promoter activity and protein expression decreased significantly by 0.31-and 0.21-fold, respectively (Fig. 4, A and B) . After transfection with HNF-1␤-H153N (DN), there was a slight increase but no statistically significant change in SOCS-3 promoter activity or protein expression (Fig. 4, A and B) .
We next examined the effects of overexpression of HNF-1␤ on the cellular proliferation of NRK-52E cells by measuring (Fig.  4E ). An Erk inhibitor (PD98059) slightly but not significantly reduced the HNF-1␤-mediated increase in [ 3 H]thymidine uptake. Thus we consider that the effects of HNF-1␤ on proliferation are mainly dependent on the STAT3 pathway in NRK-52E cells. To determine the efficiency of transfection, we transfected a GFP-expressing plasmid as a control by using the same electroporation method. As shown in Fig. 4F , the transfection efficiency was high, since ϳ70 -80% of the cells were transfected, as determined by GFP staining. was decreased significantly by 0.65-and 0.62-fold, respectively, when compared with vector only in NRK-52E cells.
Overexpression of dominant-negative HNF-1␤ and SOCS-3 suppresses phosphorylation of STAT3 and erk in NRK-
HGF stimulates HNF-1␤ expression, and HNF-1␤ promotes cell cycle at least in part via STAT3 in NRK-52E cells.
To investigate the signal transduction pathway of HGF and NHF-1␤ in the tubular cell cycle, we examined the effects of HGF on the protein expression of HNF-1␤ and SOCS-3. As shown in Fig. 6A , HGF stimulated NHF-1␤ expression and decreased SOCS-3 expression in NRK-52E cells. We also examined whether HNF-1␤ activates STAT3 or Erk in the absence of HGF. As shown in Fig. 6B , the overexpression of HNF-1␤ stimulated the phosphorylation of STAT3, as determined using anti-phospho-STAT3 (Ser-705) antibody, but did not affect the phosphorylation of Erk under our experimental conditions. We further examined whether cyclin D1 and PCNA are induced by HNF-1␤. Cyclin D1 and PCNA are well-known markers of cell proliferation. As shown in Fig. 6E , the protein expression of cyclin D1 and PCNA was increased by HNF-1␤.
Overexpression of dominant-negative HNF-1␤ inhibits tubulogenesis in 3-dimensional collagen gels in the presence of HGF.
To investigate the role of HNF-1␤ in the regeneration of tubules, we assessed the effects of dominant-negative mutant HNF-1␤-H153N on renal epithelial cell tubulogenesis. As shown in Fig. 7A , NRK-52E cells formed tubules when grown in three-dimensional (3D) collagen gels in the presence of low concentration of HGF (10 ng/ml). HGF-dependent tubule formation was strongly inhibited by expressing the dominantnegative mutant HNF-1␤-H153N and enhanced by wild type of HNF-1␤ (Fig. 7A) . Quantification of these data showed that the number of tubules was decreased by 84% in the presence of HNF-1␤-H153N (DN) compared with wild-type HNF-1␤ (Fig. 7B) , indicating that HNF-1␤ is required for tubulogenesis in renal epithelial cells.
HNF-1␤ does not affect apoptosis or LDH release in NRK-52E cells.
We performed experiments to examine whether HNF-1␤ affects apoptosis or cell damage. We measured caspase-3 activity and performed an immunoblot analysis for the cleaved caspase-3, as shown in Fig. 8 ; these markers of apoptosis were not significantly affected by the transfection of HNF-1␤. In addition, the amount of released LDH was not affected by the transfection of HNF-1␤ in both the presence and absence of 600 M H 2 O 2 , as shown in Fig. 8 . Thus, we consider that HNF-1␤ does not significantly affect apoptosis or cell damage, at least in our experimental conditions.
DISCUSSION
In this study, we demonstrate that the HNF-1␤/SOCS-3 pathway is finely regulated during ischemia/reperfusion renal tubule injury in proximal tubular cells in vivo and that HNF-1␤ regulates cellular proliferation and regeneration by regulating SOCS-3 expression and STAT3/Erk activation. Our findings suggest that the HNF-1␤/SOCS-3 pathway is of both physiological and pathological significance during ischemia/reperfusion renal injury in vivo and in vitro.
Recovery from AKI requires the replacement of damaged cells with new cells to restore the integrity of the tubular epithelium. Regeneration processes are characterized by proliferation of de-differentiated cells, followed by differentiation of daughter cells into the required cell phenotype (6, 22, 32, 33) . Noting that a similar phenomenon occurs during embryogenesis, our group and others (14, 19, 26, 28, 32, 33) have postulated that these regeneration processes may redeploy certain parts of the genetic program executed during organogenesis to reestablish proper tissue function in the kidney. A previous study (28) by our group revealed the expression of the developmental gene Wnt-4 in ischemic AKI and confirmed that this gene promotes the proliferation of renal tubular cells. We (19) also reported that the Delta-1/Notch-2/Hes-1 pathway is upregulated in proximal tubules during the recovery phase of AKI and is highly expressed in the embryonic kidney. These previous studies suggest that certain developmental genes are reexpressed during recovery from AKI and play key roles in tubule regeneration. To confirm this hypothesis, we examined the expression patterns and functions of members of the HNF-1␤ pathway in an AKI model and renal tubular cells.
This study is the first to demonstrate upregulation of HNF-1␤ and reciprocal downregulation of SOCS-3 expression in the early phase of ischemic AKI. HNF-1␤ expression was localized exclusively in the proximal tubule. The target genes of HNF-1␤ include cystic genes and other types of genes (Pkhd1, Pkd2, Kif12, Umod, and Socs-3; Refs. 11, 36). For our study, we performed a real-time quantitative PCR analysis of these target gene mRNAs for screening purposes (Fig. 1) . We detected strong signals and changes in PKD2 and SOCS-3 after ischemia/reperfusion under our experimental conditions. The protein expressions of SOCS-3 and PKD2 also changed dramatically during ischemia/reperfusion. It remains unclear why among the HNF-1␤-induced genes, only SOCS-3 and PKD2 are affected by ischemia/reperfusion AKI. However, it is likely that the HNF-1␤-induced genes can be classified into at least two groups (31), i.e., the Umod group and the Pkd2 group, which vary in their response to promoter activation with different durations of HNF-1␤ expression (31) . The HNF-1␤ induction was transient under our in vivo experimental conditions; therefore, these two groups may be differentially regulated by HNF-1␤ in the in vivo AKI model. The expression of SOCS-3 is negatively regulated by HNF-1␤ at the promoter level, as shown in our experiments and others (36) . Thus only SOCS-3 and PKD2 were affected by ischemia/reperfusion AKI under our experimental conditions. There are many candidate target proteins for HNF-1␤ during the regenerative phase of renal tubular cells in acute renal failure, such as Pkhd1, Pkd2, Kif12, Umod, and Socs-3. We were particularly interested in Pkd2 and Pkhd1 because they were reported to active the JAK-STAT pathway (4), and we observed upregulation of Pkd2 in the in vivo AKI model ( Figs. 1 and 2 ). Thus HNF-1␤-induced Pkd2 could stimulate the JAK/STAT pathway. HNF-1␤ plays an essential role during organogenesis in mammalian embryos and is highly expressed in renal tubules of the developing kidney (17) . In humans, heterozygous mutations of HNF-1␤ result in several kidney abnormalities, including formation of cysts, oligomeganephronia, renal agenesis, renal hypoplasia, and MODY5. Further, the kidneyspecific knockout of HNF-1␤ revealed defective activation of the genes Pkhd1, Pkd2, and Umod; mutations in these genes are responsible for distinct kidney defects in humans (11) . Our results agree with those of other recent studies on the importance of the HNF-1␤ pathway in regeneration of the proximal tubule. The detection of upregulation of HNF-1␤ and PKD2 expressions in proximal tubules after AKI suggests that proximal tubules are at least partially embryonic in character. Our present study is also the first to demonstrate a significant reduction of SOCS-3 in the proximal tubule after AKI. Recently, SOCS-3 has been identified as an additional direct HNF-1␤ target; Zhengdong et al. (36) have shown that the expression of SOCS-3 is increased in animals with a kidneyspecific deletion of HNF-1␤. In our study, we demonstrated that overexpression of HNF-1␤ suppresses promoter activity and protein expression of SOCS-3 in renal tubular cells and that SOCS-3 suppresses phosphorylation of STAT3 and Erk. We also demonstrated that overexpression of HNF-1␤-H153N (DN) and SOCS-3 significantly reduced [ 3 H]thymidine uptake in NRK-52E cells in the presence of HGF. These data suggest that increments of HNF-1␤ expression promote proliferation of damaged renal tubular cells and also suppress SOCS-3 expression after AKI in vivo. The suppression of SOCS-3 may also promote tubule regeneration under in vivo conditions.
We next examined the role of the HNF-1␤ signaling pathway in cell proliferation. As shown in Fig. 4E overexpression of HNF-1␤ significantly stimulated the phosphorylation of STAT3, as determined using an anti-phospho-STAT3(Ser-705) antibody, but did not affect the phosphorylation of Erk or STAT3 (Ser-727) and it upregulated cell proliferation markers such as cyclin D1 and PCNA. Thus we consider that the effects of HNF-1␤ on proliferation were mainly dependent on the STAT3 pathway in NRK-52E cells. We also performed experiments to determine whether HGF itself activates HNF-1␤ expression and suppresses SOCS-3 expression in NRK cells. As shown in In the next set of experiments in our study, we examined the location of HNF-1␤ expression in AKI by using immunohistochemistry. HNF-1␤ expression was mainly observed in the proximal tubules at 12 h after ischemia/reperfusion, and the expression of aquaporin-1 was apparently colocalized with that of HNF-1␤ in the proximal tubules (Fig. 2) . In addition, immunohistochemical investigations performed using blocking peptides confirmed the specificity of the HNF-1␤ antibody. Proximal tubular cells have been established to be highly sensitive to ischemic injury and regenerate in the nephron segments (21, 25) . Our immunohistological studies clearly identified the expression of HNF-1␤ in this segment after ischemia/reperfusion. Our in vivo results, meanwhile, strongly suggest that the HNF-1␤ pathway is capable of regulating the proliferation and regeneration of proximal tubular cells. Nonetheless, our in vivo study did not clarify the functional role of the HNF-1␤ pathway in renal tubule formation. Our next step, therefore, was to prepare a 3D collagen gel cell culture system. The purpose of preparing a 3D collagen gel cell culture system was to examine the functional role of HNF-1␤ signaling in renal tubular cells. As shown in Fig. 6 , HGF-induced tubule formation is strongly inhibited in NRK-52E cells expressing dominant-negative HNF-1␤-H153N. Wild-type HNF-1␤ stimulates tubular formation in the presence of low concentration of HGF. In some instances, it may be inappropriate to extend the interpretation of in vitro results to in vivo conditions. However, our in vitro data suggest that the HNF-1␤/SOCS-3 pathway plays a role in the regeneration of renal tubular cells after AKI. The use of other experimental approaches in the future will help to broaden understanding of the functional roles of the HNF-1␤/SOCS-3 pathway in AKI. In summary, our study has produced two novel findings. Firstly, HNF-1␤ is upregulated after ischemia/reperfusion renal tubule injury in proximal tubular cells in vivo. Secondly, HNF-1␤ controls cellular proliferation and tubule formation by regulating SOCS-3 expression and STAT3 activation. The HNF-1␤/SOCS-3 pathway may regulate the regeneration and proliferation of renal tubules after AKI. Further studies are necessary to gain a more precise understanding of the molecular mechanisms of renal recovery after ischemia/reperfusion injury.
